A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure

Background Continuous‐flow left ventricular assist systems increase the rate of survival among patients with advanced heart failure but are associated with the development of pump thrombosis. We investigated the effects of a new magnetically levitated centrifugal continuous‐flow pump that was engineered to avert thrombosis. Methods We randomly assigned patients with advanced heart failure to receive either the new centrifugal continuous‐flow pump or a commercially available axial continuous‐flow pump. Patients could be enrolled irrespective of the intended goal of pump support (bridge to transplantation or destination therapy). The primary end point was a composite of survival free of disabling stroke (with disabling stroke indicated by a modified Rankin score >3; scores range from 0 to 6, with higher scores indicating more severe disability) or survival free of reoperation to replace or remove the device at 6 months after implantation. The trial was powered for noninferiority testing of the primary end point (noninferiority margin, ‐10 percentage points). Results Of 294 patients, 152 were assigned to the centrifugal‐flow pump group and 142 to the axial‐flow pump group. In the intention‐to‐treat population, the primary end point occurred in 131 patients (86.2%) in the centrifugal‐flow pump group and in 109 (76.8%) in the axial‐flow pump group (absolute difference, 9.4 percentage points; 95% lower confidence boundary, ‐2.1 [P<0.001 for noninferiority]; hazard ratio, 0.55; 95% confidence interval [CI], 0.32 to 0.95 [two‐tailed P=0.04 for superiority]). There were no significant between‐group differences in the rates of death or disabling stroke, but reoperation for pump malfunction was less frequent in the centrifugal‐flow pump group than in the axial‐flow pump group (1 [0.7%] vs. 11 [7.7%]; hazard ratio, 0.08; 95% CI, 0.01 to 0.60; P=0.002). Suspected or confirmed pump thrombosis occurred in no patients in the centrifugal‐flow pump group and in 14 patients (10.1%) in the axial‐flow pump group. Conclusions Among patients with advanced heart failure, implantation of a fully magnetically levitated centrifugal‐flow pump was associated with better outcomes at 6 months than was implantation of an axial‐flow pump, primarily because of the lower rate of reoperation for pump malfunction. (Funded by St. Jude Medical; MOMENTUM 3 ClinicalTrials.gov number, NCT02224755.)

[1]  M. Mehra,et al.  Pump thrombosis redux. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[2]  Axel Haverich,et al.  First implantation in man of a new magnetically levitated left ventricular assist device (HeartMate III). , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  J. Cleveland,et al.  Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[4]  M. Mehra,et al.  Evaluation of von Willebrand factor with a fully magnetically levitated centrifugal continuous-flow left ventricular assist device in advanced heart failure. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[5]  R. Lazar,et al.  Cerebrovascular disease in the era of left ventricular assist devices with continuous flow: risk factors, diagnosis, and treatment. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[6]  M. Mehra,et al.  The vexing problem of thrombosis in long-term mechanical circulatory support. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[7]  G. Ewald,et al.  Unexpected abrupt increase in left ventricular assist device thrombosis. , 2014, The New England journal of medicine.

[8]  Nir Uriel,et al.  Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[9]  S. Russell,et al.  Advanced heart failure treated with continuous-flow left ventricular assist device. , 2009, The New England journal of medicine.

[10]  M. Morshuis,et al.  Fully Magnetically Levitated Left Ventricular Assist System for Treating Advanced HF: A Multicenter Study. , 2015, Journal of the American College of Cardiology.

[11]  L. Stevenson,et al.  Implant strategies change over time and impact outcomes: insights from the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). , 2013, JACC. Heart failure.

[12]  Sean Pinney,et al.  Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[13]  Nader Moazami,et al.  An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[14]  V. Mehta,et al.  Diagnosis of hemolysis and device thrombosis with lactate dehydrogenase during left ventricular assist device support. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[15]  Robert L Kormos,et al.  Seventh INTERMACS annual report: 15,000 patients and counting. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[16]  Jennifer A Cowger,et al.  A contemporary review of mechanical circulatory support. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  John Gorcsan,et al.  The NHLBI REVIVE-IT study: Understanding its discontinuation in the context of current left ventricular assist device therapy. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  F. Pagani,et al.  Treatment of device thrombus in the HeartWare HVAD: Success and outcomes depend significantly on the initial treatment strategy. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.